HedgeChatter

  • Home /
  • Tag Archives

CVM

9:04 am CEL-SCI Corp reports 146 patients enrolled in its phase iii immunotherapy head and neck cancer trial; in accordance with study design ~ 84 of the enrolled patients have been dosed with Multikine

moreView todays social media effects on CVMView the latest stocks trending across Twitter. Click to view dashboardSee who Cel is hiring next, click here to view […]

February 27, 2014 Bystocknews , Comments Off on 9:04 am CEL-SCI Corp reports 146 patients enrolled in its phase iii immunotherapy head and neck cancer trial; in accordance with study design ~ 84 of the enrolled patients have been dosed with Multikine read more

9:04 am CEL-SCI Corp reports 146 patients enrolled in its phase iii immunotherapy head and neck cancer trial; in accordance with study design ~ 84 of the enrolled patients have been dosed with Multikine

moreView todays social media effects on CVMView the latest stocks trending across Twitter. Click to view dashboardSee who Cel is hiring next, click here to view […]

February 27, 2014 Bystocknews , Comments Off on 9:04 am CEL-SCI Corp reports 146 patients enrolled in its phase iii immunotherapy head and neck cancer trial; in accordance with study design ~ 84 of the enrolled patients have been dosed with Multikine read more

CEL-SCI Reports 146 Patients Enrolled in Its Phase III Immunotherapy Head and Neck Cancer Trial

[Business Wire] – CEL-SCI Corporation today reported accelerating progress in patient enrollment in the Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine* . moreView todays social media effects on CVMView the latest stocks trending across Twitter. Click to view dashboardSee who Cel is hiring next, click here to view […]

February 27, 2014 Bystocknews , Comments Off on CEL-SCI Reports 146 Patients Enrolled in Its Phase III Immunotherapy Head and Neck Cancer Trial read more

CEL-SCI Reports 146 Patients Enrolled in Its Phase III Immunotherapy Head and Neck Cancer Trial

[Business Wire] – CEL-SCI Corporation today reported accelerating progress in patient enrollment in the Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine* . moreView todays social media effects on CVMView the latest stocks trending across Twitter. Click to view dashboardSee who Cel is hiring next, click here to view […]

February 27, 2014 Bystocknews , Comments Off on CEL-SCI Reports 146 Patients Enrolled in Its Phase III Immunotherapy Head and Neck Cancer Trial read more

Rightscorp Innovative Business Model Persuades File Sharing Users to Pay Intellectual Property Holders: Updates on Recent Coverage

[PR Newswire] – NEW YORK, Feb. 25, 2014 /PRNewswire/ — A California company, Rightscorp, Inc. (OTCQB:RIHT) is receiving the blessing of major music and movie studios by going after illegal distributors on file-sharing sites in a different way than previ moreView todays social media effects on CVMView the latest stocks trending across Twitter. Click to view dashboardSee who Cel is […]

February 25, 2014 Bystocknews , Comments Off on Rightscorp Innovative Business Model Persuades File Sharing Users to Pay Intellectual Property Holders: Updates on Recent Coverage read more